SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
WOMEN FIRST HEALTHCARE, INC.
------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
------------------------------------------------------------------------------
(Title of Class of Securities)
978150 10 0
------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2001
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
--------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 978150 10 0 Page 2 of 5 Pages
-----------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson
22-1024240
------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
------------------------------------------------------------------------------
3. SEC USE ONLY
------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------
EACH 6. SHARED VOTING POWER
REPORTING
PERSON 1,783,292 shares of Common Stock
WITH (includes shares issuable upon
exercise of warrants)
---------------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,783,292 shares of Common Stock
(includes shares issuable upon
exercise of warrants)
------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,783,292 shares of Common Stock
(includes shares issuable upon exercise of warrants)
------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.9%
------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------------------
CUSIP No. 978150 10 0 Page 3 of 5 Pages
------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson Development Corporation
22-2007137
------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
------------------------------------------------------------------------------
3. SEC USE ONLY
------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------
EACH 6. SHARED VOTING POWER
REPORTING
PERSON 1,783,292 shares of Common Stock
WITH (includes shares issuable upon
exercise of warrants)
---------------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,783,292 shares of Common Stock
(includes shares issuable upon
exercise of warrants)
------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,783,292 shares of Common Stock
(includes shares issuable upon exercise of warrants)
------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.9%
------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------------------
CUSIP No. 978150 10 0 Page 4 of 5 Pages
Amendment No. 1 to Schedule 13G
-------------------------------
Reference is hereby made to the statement on Schedule 13G filed with the
Securities and Exchange Commission on February 14, 2001 (the "Schedule 13G").
Terms defined in the Schedule 13G are used herein as so defined.
The following items of the Schedule 13G are hereby amended and restated as
follows:
ITEM 4. OWNERSHIP.
(a) Amount Beneficially Owned:
J&J: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of warrants)
JJDC: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of warrants)
(b) Percent of Class:
J&J: 7.9%
JJDC: 7.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote:
J&J: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of
warrants)
JJDC: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of
warrants)
(iii) sole power to dispose or to direct
the disposition of: -0-
(iv) shared power to dispose or to direct the disposition
of:
J&J: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of
warrants)
JJDC: 1,783,292 shares of Common Stock
(includes shares issuable upon exercise of
warrants)
CUSIP No. 978150 10 0 Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
JOHNSON & JOHNSON
By /s/ MICHAEL H. ULLMAN
---------------------------------------
Name: Michael H. Ullman
Title: Secretary
Dated: February 13, 2002
JOHNSON & JOHNSON DEVELOPMENT CORPORATION
By /s/ ERIC B. JUNG
---------------------------------------
Name: Eric B. Jung
Title: Secretary
Dated: February 13, 2002